Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Merck
Colorcon
Medtronic
Baxter

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TETRABENAZINE

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for Tetrabenazine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00219804 ↗ Efficacy and Safety of Tetrabenazine in Chorea Completed Prestwick Pharmaceuticals Phase 3 1969-12-31 The primary objective of this study was to establish the absolute reduction of chorea in participants with Huntington's disease(HD) treated with tetrabenazine or placebo
NCT00362804 ↗ Tetrabenazine for Partial Responders Completed Stanley Medical Research Institute N/A 2002-02-01 Purpose of Study: A) To improve outcome in large population of antipsychotic patients with schizophrenia or schizoaffective who are only partial responders B) To increase understanding of pharmacology and mechanisms of action underlying antipsychotic effect Hypothesis/Objectives of the Study: Tetrabenazine, through its pre-synaptic action, should augment the post-synaptic effects of an antipsychotic. Background and Rationale for the study: Preliminary evidence that other amine-depleting agents e.g., reserpine, can induce such an effect
NCT00362804 ↗ Tetrabenazine for Partial Responders Completed Centre for Addiction and Mental Health N/A 2002-02-01 Purpose of Study: A) To improve outcome in large population of antipsychotic patients with schizophrenia or schizoaffective who are only partial responders B) To increase understanding of pharmacology and mechanisms of action underlying antipsychotic effect Hypothesis/Objectives of the Study: Tetrabenazine, through its pre-synaptic action, should augment the post-synaptic effects of an antipsychotic. Background and Rationale for the study: Preliminary evidence that other amine-depleting agents e.g., reserpine, can induce such an effect
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Tetrabenazine

Condition Name

Condition Name for Tetrabenazine
Intervention Trials
Schizoaffective Disorder 2
Schizophrenia 2
Healthy 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Tetrabenazine
Intervention Trials
Huntington Disease 5
Movement Disorders 2
Schizophrenia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Tetrabenazine

Trials by Country

Trials by Country for Tetrabenazine
Location Trials
United States 29
Canada 3
France 3
India 2
Australia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Tetrabenazine
Location Trials
New York 2
Texas 2
Arkansas 1
Colorado 1
District of Columbia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Tetrabenazine

Clinical Trial Phase

Clinical Trial Phase for Tetrabenazine
Clinical Trial Phase Trials
Phase 4 2
Phase 3 4
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Tetrabenazine
Clinical Trial Phase Trials
Completed 10
Available 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Tetrabenazine

Sponsor Name

Sponsor Name for Tetrabenazine
Sponsor Trials
Dr. Reddy's Laboratories Limited 2
Prestwick Pharmaceuticals 1
H. Lundbeck A/S 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Tetrabenazine
Sponsor Trials
Other 14
Industry 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
AstraZeneca
Medtronic
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.